U.S Domestic
Available Domestic
Lab Tested
Axiolabs TB 500 5 mg Thymosin Beta 4 Lyophilized Research Vial
Injection · 5mg · vial
Axiolabs TB 500 is a synthetic fragment of thymosin beta-4, an actin-binding research peptide studied for soft tissue repair. Supplied as a powder in a 5 mg vial for reconstitution.
GMP-manufactured, each batch HPLC-verified with the Certificate of Analysis on file. TB 500 for sale with international shipping; the product page shows current availability.
Product overview
Axiolabs TB 500 5 mg Research Vial
Axiolabs TB 500 is a synthetic fragment of thymosin beta-4, supplied as a research powder in a 5 mg vial. Thymosin beta-4 is a naturally occurring peptide of 43 amino acids that binds actin, the protein that makes up much of the cell cytoskeleton, and it is studied for soft tissue repair and cell migration. Buy TB 500 here as a research material: no regulator has approved the peptide, and the vial is not a finished medicine. A local repair peptide such as BPC 157 is the usual partner in the same order.
- 5 mg of thymosin beta-4 fragment per vial
- Lyophilized research powder - needs a solvent
- GMP-manufactured - HPLC-verified per batch, COA on file
- International shipping with discreet plain packaging
How TB 500 Works
The peptide acts on actin dynamics, which is the mechanism behind the cell migration and tissue remodeling it is studied for. Its human half-life is not established, and the pharmacokinetic data that exists comes from veterinary work, where the acetylated metabolite LKKTETQ was measured in horse urine and plasma. For people there is no validated dose and no clinical efficacy data, so expectations built on recovery timelines come from vendor descriptions rather than trials. That gap separates this peptide from a drug with a label.
Reconstitution & Storage
Add bacteriostatic water down the side of the vial and swirl gently, never shake. A 5 mg vial with 2 mL gives 2.5 mg/mL, so a 2.5 mg research amount is 1 mL of solution. Keep the sealed powder cold, dry and out of light, let it reach room temperature before opening, then hold the dissolved solution at 2-8 C and do not freeze it. Because the peptide is systemic rather than local, studies often pair it with a collagen marker arm built on GHK-CU or with a growth hormone pulse from Ipamorelin.
Quality & Authenticity
Each batch is produced under GMP conditions and verified by third-party HPLC, with a Certificate of Analysis held for the batch. International orders leave in discreet plain packaging with a reship guarantee, and the product page shows current stock, which at the time of writing is out of stock.
For laboratory research only. Consult a healthcare professional before handling any peptide.
Specifications
| Trade Name | TB 500 |
| Generic Name | Thymosin beta-4 fragment |
| Manufacturer | Axiolabs |
| Dosage | 5 mg per vial |
| Package | Single vial, research powder |
| Drug Class | Actin-binding peptide, research peptide |
| Administration | Research use after reconstitution |
| Storage | Powder cold and dry; solution 2-8 C, do not freeze |
| Prescription Status | Research use only; not for human use |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | International 4-10 days |
Stacks
For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.
FAQ
Before you ask
Questions, answered
TB 500 is a synthetic fragment of thymosin beta-4, a peptide that occurs naturally in the body and binds actin, the protein that forms much of the cell cytoskeleton. Research interest is in cell migration and the repair of soft tissue such as tendon and muscle. It is a research material, not an approved medicine, and it is a different molecule from BPC 157 even though the two are often ordered together.
Add bacteriostatic water down the side of the vial and swirl it gently rather than shaking. Divide the milligrams on the label by the millilitres you add: a 5 mg vial with 2 mL gives 2.5 mg/mL, so a 2.5 mg research amount is 1 mL. Keep the solution at 2-8 C and do not freeze it, and let the sealed powder reach room temperature before opening.
There is no established human half-life for TB 500, and vendor documentation states the same. Detection work that exists is veterinary: the acetylated metabolite LKKTETQ has been measured in the urine and plasma of horses. With no human figure to work from, any schedule of loading and maintenance amounts is a research reference taken from supplier guidance rather than a measured pharmacokinetic plan.
No validated human safety profile exists for this peptide, so reported effects come from user accounts rather than trials. Injection site reactions such as redness, soreness or swelling, headache and mild malaise are the effects most often described for research peptides. A theoretical concern about cell proliferation means anyone with a cancer history should be cautious, and a known allergy to the peptide or its solvent is a reason not to use it.
Yes. Thymosin beta-4 and its derivatives, with TB-500 named as the example, sit in class S2.3 of the WADA Prohibited List, the growth factor section, and they are prohibited at all times in and out of competition. The listing is explicit about the peptide rather than covering it only as a general category. Anyone subject to testing should treat TB 500 as a banned substance without exception.
The 5 mg vial is listed on this page and the product page shows current availability and price; at the time of writing the vial is out of stock, so check the listing for restocking rather than expecting same day dispatch. Shipping is international at about 45 dollars, with orders handled in one to two business days and transit of four to ten days. Each batch is GMP-manufactured and HPLC-verified with the COA on file.
Be the first to share your experience with Axiolabs TB 500 5 mg Thymosin Beta 4 Lyophilized Research Vial
Log in to write a reviewComplete the cycle